Silencing of TRPM8 inhibits aggressive tumor phenotypes and enhances gemcitabine sensitivity in pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Silencing of TRPM8 inhibits aggressive tumor phenotypes and enhances gemcitabine sensitivity in pancreatic cancer

Published:2018-12 Issue:8 Volume:18 Page:935-944
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Liu JieFeng,Hu GuoHuang,Gong YuJing,Yu QianLe,He Bin,Li WangHao,He ZhiGuo,Hao WenJie,He ZiChao,Liu YiPing

Funder

Scientific Research Plan of Commission of Hunan Province

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference32 articles.

1. Hoxb7 promotes invasion and predicts survival in pancreatic adenocarcinoma;Nguyen Kovochich;Cancer,2013

2. Role of tissue factor expression on tumour cell invasion and growth of experimental pancreatic adenocarcinoma;Kakkar;Br J Surg,1999

3. Current and future biomarkers for pancreatic adenocarcinoma;Loosen;Tumour Biol,2017

4. Novel targets in pancreatic cancer research;Kozak;Semin Oncol,2015

5. Oncogenic trp channels;Lehen'kyi;Adv Exp Med Biol,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer;Pharmaceuticals;2024-07-09

2. Genetic and immune identification and functional analysis of TRPM8 as a potential biomarker for pancreatic adenocarcinoma proliferation;Cancer Reports;2024-06

3. Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, and immunotherapy response for pancreatic cancer patients;Frontiers in Pharmacology;2023-09-07

4. Therapeutic potential of TRPM8 channels in cancer treatment;Frontiers in Pharmacology;2023-03-22

5. Nanoparticles loaded with circ_0086375 for suppressing the tumorigenesis of pancreatic cancer by targeting the miR-646/SLC4A4 axis;Clinical & Experimental Metastasis;2022-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3